Cas 1609175-80-5,(Z)-5-(3,4-dihydroxybenzylidene)-3-((4'-(trifluoromethoxy)-[1,1-biphenyl]-3-yl)methyl)thiazolidine-2,4-dione

1609175-80-5

Post Buying Request

Basic information

Product Name: (Z)-5-(3,4-dihydroxybenzylidene)-3-((4'-(trifluoromethoxy)-[1,1-biphenyl]-3-yl)methyl)thiazolidine-2,4-dione
Synonyms: (Z)-5-(3,4-dihydroxybenzylidene)-3-((4'-(trifluoromethoxy)-[1,1-biphenyl]-3-yl)methyl)thiazolidine-2,4-dione
CAS NO:1609175-80-5
Molecular Formula:
Molecular Weight: 487.456
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (Z)-5-(3,4-dihydroxybenzylidene)-3-((4'-(trifluoromethoxy)-[1,1-biphenyl]-3-yl)methyl)thiazolidine-2,4-dione(CAS DataBase Reference)
NIST Chemistry Reference: (Z)-5-(3,4-dihydroxybenzylidene)-3-((4'-(trifluoromethoxy)-[1,1-biphenyl]-3-yl)methyl)thiazolidine-2,4-dione(1609175-80-5)
EPA Substance Registry System: (Z)-5-(3,4-dihydroxybenzylidene)-3-((4'-(trifluoromethoxy)-[1,1-biphenyl]-3-yl)methyl)thiazolidine-2,4-dione(1609175-80-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1609175-80-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1609175-80-5 Suppliers

Recommended suppliers

1609175-80-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1609175-80-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,0,9,1,7 and 5 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1609175-80:
(9*1)+(8*6)+(7*0)+(6*9)+(5*1)+(4*7)+(3*5)+(2*8)+(1*0)=175
175 % 10 = 5
So 1609175-80-5 is a valid CAS Registry Number.

1609175-80-5Upstream product

1609175-80-5Downstream Products

1609175-80-5Relevant academic research and scientific papers

PLASMINOGEN ACTIVATOR-1 INHIBITORS AND METHODS OF USE THEREOF

-

Paragraph 00209; 00217-00219, (2014/05/24)

The invention relates to plasminogen activator- 1 (PAI-1) inhibitor compounds and uses thereof in the treatment of any disease or disorder associated with elevated PAI-1. The invention includes, but is not limited to, the use of such compounds to prevent or reduce thrombosis and fibrosis, to promote thrombolysis, and to modulate lipid metabolism and treat diseases or disorders associated with elevated PAI-1, cholesterol, or lipid levels.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1609175-80-5